Health Catalyst, Inc. HCAT
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 56.28M | 70.49M | 70.76M | 74.68M | 76.32M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 56.28M | 70.49M | 70.76M | 74.68M | 76.32M |
| Cost of Revenue | 32.11M | 35.07M | 34.98M | 35.29M | 37.39M |
| Gross Profit | 24.17M | 35.42M | 35.77M | 39.39M | 38.94M |
| SG&A Expenses | 18.07M | 18.67M | 20.73M | 19.85M | 23.07M |
| Depreciation & Amortization | 9.73M | 10.98M | 12.12M | 12.88M | 12.61M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 69.31M | 74.26M | 77.50M | 77.88M | 83.98M |
| Operating Income | -13.03M | -3.77M | -6.75M | -3.20M | -7.65M |
| Income Before Tax | 40.10M | -40.22M | -110.61M | -90.65M | -22.19M |
| Income Tax Expenses | -393.00K | 315.00K | 414.00K | 379.00K | 41.00K |
| Earnings from Continuing Operations | 40.50M | -40.54M | -111.03M | -91.03M | -22.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 40.50M | -40.54M | -111.03M | -91.03M | -22.23M |
| EBIT | -13.03M | -3.77M | -6.75M | -3.20M | -7.65M |
| EBITDA | -6.40M | 4.01M | 1.87M | 6.28M | 1.76M |
| EPS Basic | 0.54 | -0.55 | -1.53 | -1.28 | -0.32 |
| Normalized Basic EPS | -0.11 | -0.06 | -0.09 | -0.07 | -0.11 |
| EPS Diluted | 0.53 | -0.55 | -1.53 | -1.28 | -0.32 |
| Normalized Diluted EPS | -0.11 | -0.06 | -0.09 | -0.07 | -0.11 |
| Average Basic Shares Outstanding | 75.39M | 73.96M | 72.59M | 71.00M | 70.38M |
| Average Diluted Shares Outstanding | 75.93M | 73.96M | 72.59M | 71.00M | 70.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |